ZENTEL 0.4 g/10 ml, oral suspension bottle, 10 ml
Active ingredients: Albendazol
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Oral suspensionbottle, 10 mlorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ZENTEL 0,4 g/10 mL, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 10 ml
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1996
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69731801CIP73297041CIP133400932970414Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALBENDAZOLEsuspension | 4 g · 100 ml de suspension buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.